Find Academic Supervisors

• Pulmonary Disease
• Critical Care Medicine
• Thrombosis
• +4 more

Elizabeth A. Middleton, MD, is an Assistant Professor in the Department of Internal Medicine at the University of Utah. She holds triple board certification from the American Board of Internal Medicine in Critical Care Medicine, Pulmonary Disease, and Internal Medicine. Her academic appointments reflect specialization in pulmonary/critical care medicine within the Division of Public Health. Education: Fellowship in Pulmonary/Critical Care Medicine, University of Utah Chief Resident in Internal Medicine, University of Utah Residency in Internal Medicine, University of Utah MD from University of Utah School of Medicine BS in Behavioral and Health Sciences, University of Utah Research Focus: Dr. Middleton investigates hematological responses in critical illnesses, with emphasis on platelet biology, immunothrombosis mechanisms in sepsis and COVID-19, megakaryocyte function, and neutrophil extracellular traps (NETs). Her work bridges pulmonary medicine and hematology, examining how coagulation abnormalities contribute to respiratory failure in infectious diseases. Publication Trends: Her recent articles (2021-2024) demonstrate consistent focus on platelet dysfunction in sepsis and COVID-19, with innovations in understanding thromboinflammatory pathways. Research frequently examines transcriptomic regulation of platelets, extracellular vesicles, autophagy mechanisms, and clinical applications for anticoagulation therapies. Awards & Advising: No awards or student advising relationships are documented in the provided text. Collaborative research is evident through multicenter clinical trials including the ACTIV-3b/TESICO and PassITON COVID-19 studies.

David YanezView profile

Professor

• Biostatistics
• Clinical Trials
• Cardiovascular Disease
• +5 more

David Yanez serves as Professor of Biostatistics & Bioinformatics at Duke University School of Medicine, holding dual appointments in the Duke Clinical Research Institute (DCRI) and Biostatistics, Epidemiology, and Research Design (BERD) Methods Core. His methodological expertise drives collaborative research across cardiovascular, neurological, and surgical disciplines while mentoring through BIOSTAT 718: Analysis of Correlated and Longitudinal Data. Education Ph.D. in Statistics/Biostatistics, Arizona State University (1993) Research Focus Dr. Yanez specializes in advanced biostatistical applications for complex clinical questions, with particular emphasis on longitudinal data modeling , clinical trial design under exception from informed consent , and multiparameter monitoring in critical care settings . His work bridges statistical innovation with real-world medical challenges in pain management, perioperative safety, and emergency pediatrics, often leveraging large multicenter datasets to generate evidence for practice-changing interventions. Publication Trends Analysis of his recent publications reveals three dominant trajectories: (1) Methodological refinement of intraoperative monitoring systems through artifact detection algorithms, (2) Optimization of community consultation protocols for emergency research during pandemics, and (3) Development of specialized hemostasis reference ranges for obstetric populations. These threads demonstrate his capacity to adapt statistical frameworks to rapidly evolving clinical environments while maintaining rigorous methodological standards. Grant Portfolio Splanchnic Nerve Modulation In Heart Failure (Splanchnic X) (NHLBI, 2024-2029): Principal statistical leadership for neural modulation trial ASD Language Impairment Assessment (NIH, 2025-2027): Remote assessment protocol development IMPACt-LBP Implementation Trial (NIH, 2021-2026): Multidisciplinary conservative care model evaluation PreVent 2 Study (NIH, 2022-2026): Endotracheal tube comparison for pneumonia prevention Electromagnetic Interference Study (OHSU, 2023-2025): ICD safety during surgical procedures TEMPLE Trial (OHSU, 2022-2023): Hemodynamic management post-spinal cord injury Research Infrastructure As a core DCRI member, Dr. Yanez contributes to one of the world's largest academic clinical research organizations, directing statistical components for >50 active trials. His BERD Methods Core role involves developing standardized analytical pipelines for Duke's enterprise research data warehouse, with recent focus on integrating remote patient monitoring data into traditional clinical trial frameworks.

Ozlem YalcinView profile

Professor

• Hemorheology
• Hemodynamics
• Vascular Biology
• +5 more

Ozlem Yalcin is a Professor of Physiology at the School of Medicine, Koc University in Istanbul, Turkey. She heads the Hemorheology, Hemodynamics and Vascular Biology Laboratory and serves as Principal Investigator for multiple research projects focused on red blood cell mechanics and microcirculation. Dr. Yalcin earned her Bachelor's Degree (1997), Master's Degree (2001), and PhD (2007) from Akdeniz University. Her extensive academic background has positioned her as a leading researcher in hemorheology and vascular biology. Her research interests center on hemorheology, hemodynamics, and vascular biology, with particular focus on red blood cell mechanics, erythrocyte aggregation, and microcirculatory blood flow. Dr. Yalcin's laboratory investigates the relationship between blood flow properties and tissue perfusion, with emphasis on the role of red blood cell mechanical properties in determining hemodynamic behavior. Analysis of her recent publications (2021-2024) shows a consistent research trajectory in hemorheology, with increasing focus on clinical applications, molecular mechanisms of red blood cell function, and technological innovations for blood diagnostics. Her work spans basic science investigations of erythrocyte signaling pathways to clinical studies examining blood rheology in various disease states including thalassemia, sickle cell disease, and chronic wounds. Dr. Yalcin leads a research team consisting of graduate and medical students who contribute to her laboratory's investigations. Her laboratory is equipped with advanced instrumentation for hemodynamics, vascular physiology, hemorheology, and proteomics, enabling comprehensive studies from molecular mechanisms to whole-organism physiology. She has made significant contributions to understanding the role of red blood cell mechanics in microcirculatory blood flow, particularly how erythrocyte deformability and aggregation affect tissue perfusion and vascular function. Her work has important clinical implications for conditions where blood flow properties are altered, such as in hemoglobinopathies, cardiovascular diseases, and during blood storage for transfusion.

• Cardiology
• Heart Disease
• Vasoactive Substances
• +8 more

Adel Schwertani is a Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site. He is affiliated with the Cardiovascular Health Across the Lifespan Program within the Centre for Translational Biology and works in the Department of Medicine, Division of Cardiology at the MUHC. Dr. Schwertani's research focuses on the role of vasoactive and structural proteins in the pathogenesis of cardiovascular diseases including atherosclerosis, myocardial infarction, aortic valve disease, and pulmonary hypertension. Along with his collaborators, he investigates the role of stem cells in cardiac regeneration and personalized drug testing. His laboratory recently identified a new mediator in the pathogenesis of thrombosis and is working with national and international collaborators to develop new therapeutic approaches for pulmonary emboli and deep vein thrombosis. His publication record demonstrates consistent contributions to understanding the molecular mechanisms of cardiovascular disease, particularly in the areas of aortic valve stenosis, lipoprotein(a) effects on cardiovascular tissues, and novel approaches to cardiac repair. His work bridges basic science with clinical applications, focusing on translating laboratory findings into potential therapeutic strategies for cardiovascular conditions. Dr. Schwertani actively collaborates with researchers across multiple institutions, as evidenced by his co-authorship on systematic reviews and meta-analyses of preclinical trials in cardiac regeneration. His research program appears to be well-integrated within the cardiovascular research community at McGill University and the RI-MUHC.

Gry Hulsart BillströmView profile

Assistant Professor

• Biomaterials
• Regenerative Medicine
• Tissue Engineering
• +9 more

Gry Hulsart Billström is an Assistant Professor at Uppsala University's Department of Medical Cell Biology , Faculty of Medicine. She also serves as a Supervisor at the Department of Materials Science, Medical Technology division. Her research group focuses on translational bioprinting and regenerative biomaterials for bone repair. Primary Affiliation: Department of Medical Cell Biology, Faculty of Medicine Secondary Affiliation: Department of Materials Science, Medical Technology Research Interests: Dr. Billström leads the Translational Bioprinting group, developing bioprinted constructs and smart biomaterials for bone regeneration. Her work emphasizes 3D bioprinting , regenerative medicine , and in vivo imaging to visualize mechanisms of biomaterials. She investigates calcium phosphate composites, polymer-based scaffolds, and immune responses to implants. Recent Publications: Her 15 most recent articles demonstrate expertise in bioprinting, implant coatings, and bone regeneration techniques. Key topics include magnesium-fiber reinforced bone cements , CD69-targeted PET imaging , and bioactive implant surface modifications . These studies span in vitro and in vivo models with clinical translation potential. Labs & Teams: She directs the Translational Bioprinting group, collaborating across departments and disciplines to bridge basic science and clinical applications in orthopedics and regenerative medicine.

Lize van VulpenView profile

Assistant Professor

• Hemophilia
• Bleeding Disorders
• Regenerative Medicine
• +5 more

Lize van Vulpen is an Assistant Professor at the UMC Utrecht Brain Center, specializing in bleeding disorders within the Regenerative Medicine & Stem Cells strategic program. Her research focuses on optimizing care for patients with inherited bleeding disorders through multidisciplinary approaches involving physiotherapy, nursing, and novel therapeutic modalities. Contact: lvulpen2@umcutrecht.nl Research areas: Hemophilia, Von Willebrand disease, thrombin generation, regenerative medicine Key projects: Development of clinical guidelines, evaluation of coagulation factor testing, subclinical joint bleeding monitoring via MRI Her recent publications highlight collaborations on bleeding phenotypes, prophylaxis efficacy, and multidisciplinary interventions in hemophilia care.

Karin van GalenView profile

Assistant Professor

• Hematology
• Thrombosis and Hemostasis
• Inherited Bleeding Disorders
• +3 more

Karin van Galen is an Assistant Professor in medical research at the Utrecht University Medical Center, focusing on inherited bleeding disorders. She works within the Child Health strategic program and specializes in hematology, particularly Von Willebrand disease and hemophilia. Her clinical role as a Consultant Hematologist includes treating benign hematological conditions and leading post-doctoral research on pregnancy-related bleeding and heavy menstrual bleeding in adolescents. Research Interests: She aims to improve patient care through multidisciplinary studies, including physiotherapy and nursing interventions, and novel treatment modalities for bleeding disorders. Her work addresses joint bleeding, pregnancy outcomes, and adolescent menstrual health, with a strong advocacy focus for women and girls. Scientific Contributions: Recent publications highlight her expertise in bleeding disorders during pregnancy, sports-related bleeding risks, and diagnostic testing limitations. She collaborates on international studies and supervises PhD students. Advocacy and Leadership: Karin van Galen is a prominent advocate for women's health in bleeding disorders and contributes to clinical guidelines and research frameworks.

Karin LeidermanView profile

Associate Professor

• Blood Coagulation
• Mathematical Biology
• Computational Biofluid Dynamics
• +3 more

Karin Leiderman, PhD, is an Associate Professor in the Department of Mathematics and a member of the UNC Lineberger Comprehensive Cancer Center. She also holds appointments in the Department of Biochemistry and Biophysics and the Computational Medicine Program at the University of North Carolina at Chapel Hill. Her research integrates mathematical modeling, computational simulations, and experimental approaches to study biochemical and biophysical mechanisms in blood coagulation, clot formation, and bleeding disorders with applications in hemophilia and cancer-associated thrombosis. She leads the Leiderman Research Group, which develops open-source software frameworks like clotFoam for simulating thrombus formation under flow. Recent publications highlight her work on: Mathematical analysis of anticoagulant drugs (emicizumab, concizumab) and their impact on coagulation Computational modeling of lipid surface enzyme kinetics and HIV-1 Env protein binding Development of multiscale models for hemostasis and thrombosis Scientific awards include: NSF CAREER Award (2020) Colorado School of Mines Faculty Excellence Award (2021) W.M. Keck Graduate Student Mentorship Award (2020) Invited State-of-the-Art Speaker at ISTH (2022) Dr. Leiderman has mentored numerous graduate and undergraduate students, including Jamie Madrigal (PhD, UNC), Kenji Miyazawa (PhD, UNC), and Nicholas Danes (PhD, Colorado School of Mines). Her research is supported by NIH R01 funding and focuses on contextualizing findings across mathematical and biological communities.

M. Ryan SmithView profile

Associate Professor

• Veterinary Emergency Medicine
• Critical Care
• Anaphylaxis
• +4 more

M. Ryan Smith serves as Associate Professor of Emergency and Critical Care within the Department of Veterinary Clinical Sciences at Louisiana State University's School of Veterinary Medicine. His clinical and research expertise centers on veterinary anaphylaxis management and coagulation disorder evaluation, with particular focus on viscoelastic testing applications in emergency settings. Dr. Smith's educational foundation includes: DVM, Louisiana State University, 2009 His research program investigates the pathophysiology of canine anaphylaxis, hemostatic derangements in critical illness, and point-of-care coagulation testing methodologies. Current projects examine trauma blood product applications and coagulation parameter stability in processed blood samples, directly addressing clinical challenges in veterinary emergency medicine. This work bridges basic physiological principles with practical diagnostic and therapeutic approaches for acute care scenarios. Analysis of Dr. Smith's publication record (2020-2024) reveals consistent contributions to veterinary emergency medicine literature, with increasing methodological sophistication from case reports to multi-year clinical studies. His work predominantly appears in specialty journals like Journal of Veterinary Emergency and Critical Care and Frontiers in Veterinary Science , focusing on clinically actionable insights for anaphylaxis management and coagulation testing. Dr. Smith's scholarly recognition includes: Multiple Dean's Teacher Merit Honor Roll awards (2019-2023) 2021 Third Place in Student Clinical Research (Phi Zeta Research Emphasis Day) His research program maintains active funding through industry partnerships (Cellphire, Inc.) and institutional programs (LSU CORP, NIH Veterinary Scholars). Current grants support trauma blood product trials, coagulation testing validation, and anaphylaxis epidemiology studies. Dr. Smith actively mentors student researchers through structured programs that integrate clinical observations with laboratory investigations. Within the Department of Veterinary Clinical Sciences, Dr. Smith leads research initiatives focused on advancing emergency coagulation diagnostics and anaphylaxis protocols. His team collaborates across disciplines to translate research findings into clinical practice improvements, maintaining strong connections between the School of Veterinary Medicine's teaching hospital and research enterprise.

• Breast Cancer
• Thrombosis
• Immunomodulation
• +3 more

Dr. Kyrtania Pather serves as a Lecturer in the Department of Family Medicine at the University of the Witwatersrand, Johannesburg. Her academic appointment bridges clinical medicine and translational research within South Africa's premier medical faculty. Her research program spans two critical domains: Oncology-Hematology Interface : Investigating how breast cancer hormone therapies (tamoxifen/anastrozole) induce hypercoagulation through estrogen receptor pathways, with implications for cancer-associated thrombosis Medical Education Innovation : Developing gamified interventions to combat antimicrobial resistance through behavioral change strategies Dr. Pather's publication record demonstrates consistent output in high-impact journals including Scientific Reports and Thrombosis Research, showing evolving focus from mechanistic cancer studies (2019-2022) toward educational applications (2023-2024). Her work reveals expertise in secretomics, ex vivo modeling, and educational intervention design. As a Family Medicine lecturer, she contributes to clinical training while maintaining active research in cancer complications and antimicrobial stewardship education. Her position enables direct translation of research findings into medical curricula and clinical practice guidelines at Wits' affiliated teaching hospitals.

Chong Kok HingView profile

Senior Lecturer

• Thermal Fluids
• Renewable Energy
• Biomass Combustion
• +3 more

Dr. Chong Kok Hing serves as a Senior Lecturer in the Faculty of Engineering, Computing and Science at Swinburne University of Technology Sarawak campus. His academic credentials include a PhD in Mechanical Engineering from Universiti Malaysia Sarawak (UNIMAS), along with Bachelor of Engineering (Hons) and Master of Engineering degrees from the same institution. As a registered Professional Engineer with the Board of Engineers Malaysia and Chartered Engineer with the Institution of Mechanical Engineers (UK), he bridges academic theory with professional engineering practice. Dr. Chong's research program focuses on critical energy challenges, particularly in thermal fluids, renewable energy systems, biomass combustion technologies, and sustainable energy management. His work demonstrates strong regional relevance with emphasis on energy-efficient building solutions for Sarawak, as evidenced by his SRDC-funded project 'Towards Energy-Efficient Buildings in Sarawak.' His research integrates computational modeling with experimental validation across diverse applications from HVAC systems to biomass-to-energy conversion. The publication analysis reveals a consistent research trajectory with 11 publications between 2014-2021, primarily in mechanical engineering and energy journals. His work shows increasing focus on renewable energy applications, with 6 of his 11 publications appearing in 2021 alone. The research spans fundamental materials science (composites, fracture mechanics) to applied building services engineering (smoke control, ventilation systems), demonstrating both breadth and depth in mechanical engineering applications. Winner, Innovate Malaysia Design Competition (Shell Design Challenge) 2019 Success in Phase 3 Shell Eco-marathon Asia 2020, Malaysia Adobe Innovation Grant recipient 2021 Swinburne Sarawak Learning and Teaching Grant recipient 2020 Dr. Chong maintains active supervision of research students, with opportunities available in thermal fluids, renewable energy, and sustainable energy management. His research program is supported by multiple grants including the SRDC Catalyst Grant 2020, Adobe Innovation Grant 2021, and IEEE Humanitarian Activities Committee grant 2021, indicating strong funding support for his research directions. His professional memberships with IMechE, BEM, and ASHRAE provide valuable industry connections for student projects and research collaborations.

• Pathology
• Oncological Pathology
• Histology
• +4 more

Professor Radoslav Gajanin is a full Professor at the Faculty of Medicine, University of Banja Luka, specializing in Pathological Anatomy. Elected to his current rank on July 6, 2015, he teaches across all academic cycles in disciplines including Histology, Embryology, Pathological Anatomy, and Oncological Pathology. His research focuses on molecular pathology, cancer biomarkers, and pharmacological interventions in disease models. Professor Gajanin has published extensively since 2000, with recent work (2023-2025) appearing in high-impact journals such as INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES and Frontiers in Pharmacology. His research examines molecular mechanisms in cancer, organ protection strategies, and genetic factors in disease. His publication trends show consistent contributions to pathology, with increasing focus on molecular biomarkers and translational research in recent years. His work spans multiple organ systems including breast, lung, gastrointestinal tract, and endocrine tissues, with applications to both diagnosis and therapeutic development. Professor Gajanin actively supervises students at all academic levels and has contributed to numerous collaborative research projects. His teaching and research activities demonstrate a strong commitment to advancing medical education and pathology research at the University of Banja Luka. His laboratory work involves histopathological analysis, molecular techniques, and animal models of disease, supporting both his research and educational missions. Through his extensive publication record and teaching responsibilities, Professor Gajanin has established himself as a leading figure in pathology education and research in the region.

Paul F LindholmView profile

Professor

• Hemostasis
• Transfusion Medicine
• Prostate Cancer
• +5 more

Paul F Lindholm, MD is a Professor and Director of Hemostasis in the Department of Pathology at Northwestern University Feinberg School of Medicine, specializing in transfusion medicine, hemostasis disorders, and prostate cancer research with significant contributions to platelet function testing and cancer cell invasion mechanisms. Education: MD: University of Minnesota (1983) Residency: Univ. of Minnesota Hospital & Clinic, Pathology and Laboratory Medicine (1988) Fellowship: National Cancer Institute, National Institutes of Health, Molecular Virology (1994) Research Focus: Dr. Lindholm's primary research spans hemostasis/thrombosis and prostate cancer biology. His hemostasis work demonstrates that reversing antiplatelet therapy improves outcomes in intracerebral hemorrhage patients, utilizing ROTEM viscoelastic testing and platelet function assays. In cancer research, he identified RhoA/NF-κB pathways driving prostate cancer invasion through monocyte cross-communication involving MCP-1 cytokines. Publication Trends: Recent work (2024-2025) emphasizes clinical hemostasis applications, including red blood cell transfusion optimization, biomarkers for hematoma expansion prediction, P2Y12 inhibitor impacts on stroke, and RhD phenotype management strategies, reflecting translational focus on improving bleeding disorder treatments and transfusion safety. Awards: Co-Investigator, Northwestern Medicine Academy for Quality and Safety Improvement (2022) CHilled Platelet Study (CHIPS), Sub-Investigator (2022) Quality Practices Committee Service Recognition, College of American Pathologists (2021) Grants & Collaborations: Leads NIH-funded studies on intracerebral hemorrhage biomarkers with Drs. Naidech and Kwaan, demonstrating platelet dysfunction links to hemorrhage expansion. Previously managed national grants investigating prostate cancer invasion mechanisms and tumor microenvironment interactions, with ongoing projects on antiphospholipid antibodies with Dr. Ming Zhao. Laboratory & Teams: Directs Northwestern's hemostasis laboratory performing platelet function assays and ROTEM testing for bleeding disorder management. Contributes to transfusion medicine initiatives evaluating thrombosis risk factors, coagulation factor replacement, and innovative platelet transfusion protocols through collaborations with the College of American Pathologists and Hemostasis and Thrombosis Research Society.

Debbie LeeView profile

Assistant Professor

• Pain Medicine
• Physical Medicine and Rehabilitation
• Interventional Spine Procedures
• +3 more

Debbie Lee, MD serves as an Assistant Professor in the Department of Physical Medicine and Rehabilitation at Northwestern University's Feinberg School of Medicine, with clinical affiliations at Shirley Ryan AbilityLab and Northwestern Memorial Hospital. Her educational pathway includes: BSN: University of Pennsylvania (2008) Other: Bryn Mawr College (2011) MD: Stony Brook University Medical School (2016) Intern: NYU Winthrop Hospital, Internal Medicine (2017) Residency: Northwestern University/Shirley Ryan Abilitylab, PM&R (2020) Fellowship: University of Colorado, Pain Medicine (2021) Dr. Lee's research integrates clinical pain management with rehabilitation medicine , focusing on interventional spine procedures, diagnostic challenges in complex musculoskeletal disorders, and endocrine complications of pain interventions. Her work bridges procedural expertise with educational innovation in pain medicine training. Recent publications (2020-2024) reveal a dual trajectory: clinically-oriented case studies addressing rare complications in interventional pain management (e.g., Quebec Platelet Disorder, adrenal suppression), alongside leadership in medical education frameworks like the Pain Medicine Milestones 2.0 initiative. This reflects her commitment to both patient-specific problem solving and systemic improvements in specialty training. Her professional recognition includes: Outstanding Teacher Award (Feinberg School of Medicine, 2024) Sarah Baskin Resident Research Award (Shirley Ryan Abilitylab, 2021) Walter E. Heller Chief Resident Award (Shirley Ryan Abilitylab, 2019) Dr. Lee actively shapes her field through national leadership roles including the ACGME Pain Medicine Milestone Working Group, AAPM&R Education Content Advisory Committee, and the AAMC Resident Fellow Council. Her clinical practice emphasizes complex pain rehabilitation within the Shirley Ryan AbilityLab ecosystem. She maintains active membership in key professional societies: International Pain and Spine Intervention Society (IPSIS), Association of Academic Physiatrists (AAP), and American Academy of Physical Medicine & Rehabilitation (AAPM&R), driving collaboration across rehabilitation and pain medicine domains.

• Cardiovascular Surgery
• Cardiac Surgery
• Vascular Surgery
• +3 more

Faruk Serhatlioglu serves as Assistant Professor and Head of the Department of Cardiovascular Surgery within the Department of Surgical Medical Sciences at Nigde Omer Halisdemir University's Faculty of Medicine. His clinical and academic work focuses on advancing cardiovascular surgical techniques and outcomes. His educational background includes: Medical Specialization in Cardiovascular Surgery, Erciyes University (2001-2007) M.D., Trakya University, Faculty of Medicine (1990-1996) Dr. Serhatlioglu's research centers on biomarker validation in coronary artery disease, vascular thrombosis mechanisms, and surgical complication management. His work bridges laboratory findings with clinical applications, particularly in inflammatory markers for disease severity assessment and innovative solutions for complex vascular cases like carotid body tumors and hemodialysis access complications. He frequently employs case report methodology to document rare presentations. Analysis of his 15 most recent publications reveals evolving expertise from foundational studies on cardiopulmonary bypass (2014-2016) toward contemporary biomarker research (2023-2024). Current work emphasizes immune-inflammation metrics in saphenous vein graft disease and glucose-lymphocyte ratios for coronary severity stratification, demonstrating consistent focus on improving diagnostic precision in vascular pathologies. With over 20 peer-reviewed publications spanning SCI-expanded, Scopus, and national journals, his contributions enhance understanding of cardiovascular surgical outcomes and complications across diverse patient populations.